These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

544 related items for PubMed ID: 12460907

  • 1. Constitutive overexpression of cyclin D1 but not cyclin E confers acute resistance to antiestrogens in T-47D breast cancer cells.
    Hui R, Finney GL, Carroll JS, Lee CS, Musgrove EA, Sutherland RL.
    Cancer Res; 2002 Dec 01; 62(23):6916-23. PubMed ID: 12460907
    [Abstract] [Full Text] [Related]

  • 2. Mechanisms of growth arrest by c-myc antisense oligonucleotides in MCF-7 breast cancer cells: implications for the antiproliferative effects of antiestrogens.
    Carroll JS, Swarbrick A, Musgrove EA, Sutherland RL.
    Cancer Res; 2002 Jun 01; 62(11):3126-31. PubMed ID: 12036924
    [Abstract] [Full Text] [Related]

  • 3. Cyclin D1 overexpression induces progestin resistance in T-47D breast cancer cells despite p27(Kip1) association with cyclin E-Cdk2.
    Musgrove EA, Hunter LJ, Lee CS, Swarbrick A, Hui R, Sutherland RL.
    J Biol Chem; 2001 Dec 14; 276(50):47675-83. PubMed ID: 11590147
    [Abstract] [Full Text] [Related]

  • 4. Involvement of G1/S cyclins in estrogen-independent proliferation of estrogen receptor-positive breast cancer cells.
    Bindels EM, Lallemand F, Balkenende A, Verwoerd D, Michalides R.
    Oncogene; 2002 Nov 21; 21(53):8158-65. PubMed ID: 12444551
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Lycopene inhibition of cell cycle progression in breast and endometrial cancer cells is associated with reduction in cyclin D levels and retention of p27(Kip1) in the cyclin E-cdk2 complexes.
    Nahum A, Hirsch K, Danilenko M, Watts CK, Prall OW, Levy J, Sharoni Y.
    Oncogene; 2001 Jun 07; 20(26):3428-36. PubMed ID: 11423993
    [Abstract] [Full Text] [Related]

  • 8. Ectopic expression of cyclin E in estrogen responsive cells abrogates antiestrogen mediated growth arrest.
    Dhillon NK, Mudryj M.
    Oncogene; 2002 Jul 11; 21(30):4626-34. PubMed ID: 12096339
    [Abstract] [Full Text] [Related]

  • 9. Antiestrogen inhibition of cell cycle progression in breast cancer cells in associated with inhibition of cyclin-dependent kinase activity and decreased retinoblastoma protein phosphorylation.
    Watts CK, Brady A, Sarcevic B, deFazio A, Musgrove EA, Sutherland RL.
    Mol Endocrinol; 1995 Dec 11; 9(12):1804-13. PubMed ID: 8614416
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2.
    Prall OW, Sarcevic B, Musgrove EA, Watts CK, Sutherland RL.
    J Biol Chem; 1997 Apr 18; 272(16):10882-94. PubMed ID: 9099745
    [Abstract] [Full Text] [Related]

  • 13. Lack of relationship between CDK activity and G1 cyclin expression in breast cancer cells.
    Sweeney KJ, Swarbrick A, Sutherland RL, Musgrove EA.
    Oncogene; 1998 Jun 04; 16(22):2865-78. PubMed ID: 9671407
    [Abstract] [Full Text] [Related]

  • 14. Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53.
    Rao S, Lowe M, Herliczek TW, Keyomarsi K.
    Oncogene; 1998 Nov 05; 17(18):2393-402. PubMed ID: 9811471
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
    Coppock DL, Buffolino P, Kopman C, Nathanson L.
    Exp Cell Res; 1995 Nov 05; 221(1):92-102. PubMed ID: 7589260
    [Abstract] [Full Text] [Related]

  • 16. Reduction of Cdc25A contributes to cyclin E1-Cdk2 inhibition at senescence in human mammary epithelial cells.
    Sandhu C, Donovan J, Bhattacharya N, Stampfer M, Worland P, Slingerland J.
    Oncogene; 2000 Nov 09; 19(47):5314-23. PubMed ID: 11103932
    [Abstract] [Full Text] [Related]

  • 17. Cyclin D2 activates Cdk2 in preference to Cdk4 in human breast epithelial cells.
    Sweeney KJ, Sarcevic B, Sutherland RL, Musgrove EA.
    Oncogene; 1997 Mar 20; 14(11):1329-40. PubMed ID: 9178893
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)-epigallocatechin-3-gallate.
    Liang YC, Lin-Shiau SY, Chen CF, Lin JK.
    J Cell Biochem; 1999 Oct 01; 75(1):1-12. PubMed ID: 10462699
    [Abstract] [Full Text] [Related]

  • 19. Multifaceted regulation of cell cycle progression by estrogen: regulation of Cdk inhibitors and Cdc25A independent of cyclin D1-Cdk4 function.
    Foster JS, Henley DC, Bukovsky A, Seth P, Wimalasena J.
    Mol Cell Biol; 2001 Feb 01; 21(3):794-810. PubMed ID: 11154267
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.